Center for Innovation & Value Research’s Post

Earlier this month, Sarah Butler, chief commercial officer at ADVI Health, spoke with Pharmacy Times to discuss the potential impact of the #InflationReductionAct on drug prices and #patientaccess. Additionally, Sarah elaborated on some of the bigger challenges for patients such as managing the cost of medication, the upcoming election, and how pharmacists and other #healthcare providers can collaborate with payers to help ensure access and affordability. Read more on Sarah's insights: https://lnkd.in/etjHe-BQ

Discover the power of #HubServices in enhancing patient engagement and health outcomes. Our latest whitepaper dives deep into how these services simplify the journey for patients accessing specialty drugs, making a real-world difference. It's time to rethink patient support ➡️ https://hubs.li/Q02pQJVq0 #HealthTech #SpecialtyPharma #PatientEngagement

DKI Health’s Jamie Culp and the National Bleeding Disorders Foundation's Philip Gattone presented “Amplifying Patient Voice in Market Access” at the 4th Chief Patient Officer Summit (#CPOSummit). What to know: • Health insurers are covering fewer drugs and making them harder to get. • New utilization management (UM) tactics emerge as payers and pharma fight over cost sharing: patients pay the heavy price. • Payers apply artificial intelligence (AI) to limit patient care—sometimes against clinician opinion and Medicare rules. • Drug access has been protected by patient advocacy in legislatures, courts, and prescription drug affordability boards (PDAB). Patients and advocates can be a difference-maker in winning and maintaining access—if we understand and address their needs. • NBDF’s Comprehensive Care Sustainability Collaborative shows the opportunity for collaboration with payers, providers, and patients to ensure treatment access. #DKImpact #patientvoice #marketaccess

The Final #CMS ruling will create the most significant changes to the medication adherence programs since it was first introduced into the #StarRatings program. Register now for the Digital Strategies to Improve Medication Adherence and Health Equity Webinar with Nicole Grevenitz, Reva Sheehan, and Brian Heacox on May 8, 2024 at 11am PT / 2 pm ET to gain insights into some of our best-performing #medicationadherence programs. https://hubs.ly/Q02v5B5p0

How will you manage the CMS Medication Adherence Measure Changes? mPulse Decision Point by mPulse HealthTrio by mPulse Reva Sheehan Brian Heacox Nicole Grevenitz #medicare #digitalhealth

Ouch 😱 The report is well done, but is this really new news? You don't have to wait to improve the pharmacy benefits experience for your members, or to save money by optimizing your current PBM contract utilization. Pharmacy Navigation is the benefit that fills the gap in your employee benefits offering now. It's seamless. It's easy. It works. #rxnavigation #drugprices #hrinnovation #hrbenefits Scripta Insights

Our new whitepaper dives into the evolving world of pharmacy benefit management. Learn how forward-thinking health plans are gaining control over drug spend and optimizing medication therapy with innovative PBM strategies. Kudos to our POCP contributors who put this insightful content together: Pooja Babbrah, Kelee Petzelt & Michael Burger. https://hubs.li/Q02vJWQm0

No matter where you turn these days the topic of AI is front and center. There are many creative ways to use AI/ML/LLM across different industries. ArisGlobal is defining several innovative approaches using intelligent automation to help our life science partners. One area of focus for us is patient advocacy. Please take a moment to read this article written by our Chief Safety Product Officer (Beena Wood) to learn a bit more on a particular use case. You can also learn more by reviewing our latest automated enhancement solution LifeSphere NavaX. https://lnkd.in/gxBgittm #patientadvocacy #patientsafety #aiadoption

This report describes the Committee on Oversight and Accountability’s findings that PBMs inflate prescription drug costs and interfere with patient care for their own financial benefit. - This is the last sentence on page 3!!! Employers!!! It is very important that you realize that this report and the FTC report, document how your PBM is inflating your pharmacy benefit cost and your members' cost while possibly exposing your members to undo side effects from the newest and most expensive medications where they profit the most. This is public knowledge and you have no excuse not to act!!! Please insist those responsible for your pharmacy benefit program become active in your regional or national healthcare purchasing organizations like PBGH, DFWBGH, HBCH, Florida Alliance for Healthcare Value, NCBGH, WHA and of course the National Alliance of Health Care Purchaser Coalition. They are working hard to provide their members with all of the information necessary to ensure CAA compliance and eliminate legal liability for their members. Please contact me if you are interested in a Fiduciary Independent Utilization Management firm proven to provide Better Outcomes and Lower Cost by removing the conflicts of interest with your PBM both selecting your medications and profiting from dispensing your medications from their mail and specialty pharmacies where they receive "class of trade" financial incentives (not just rebates). mmincy@us-rxcare.com #CEO #COO #CFO #CHRO #CAA #Fiduciary #DoTheRightThing

In Parexel's latest edition of the New Medicines, Novel Insights newsletter, @Alex Gee, Senior Director, Parexel Access Consulting, shares the keys to establishing market access, why patient insights are essential, and how every drug developer can benefit from bringing access experts in by phase II. Learn how to demonstrate clinical and economic value, positioning your product for favorable coverage decisions that benefit the appropriate patient population. Like and subscribe to stay updated with more #NovelInsights! #MarketAccess #PatientEngagement #Reimbursement #HealthEconomics